Navigation Links
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
Date:11/18/2009

s, or if they are taking anticoagulants (e.g., warfarin) or taking NSAIDs (e.g., ibuprofen or naproxen) for a long time, they should talk to their doctor, as they may be at an increased risk of bleeding.

If patients plan to have surgery or a dental procedure, they should tell their doctors that they are taking Effient. Patients should not stop taking Effient without first talking to the doctor who prescribed it for them, as this may result in increased risk of a clot in their stent, a heart attack or death.

Patients should get medical attention right away if they develop any of the following unexpected symptoms: fever, weakness, yellowing of the skin or eyes, or if skin becomes very pale or dotted with purple spots. These symptoms may be signs of a rare but potentially life-threatening condition called TTP, which has been reported with other medicines in this class that are like Effient, sometimes after a short time (less than 2 weeks).

For more information about Effient including prescribing information, please visit www.Effient.com.

About Daiichi Sankyo

A global pharmaceutical innovator, Daiichi Sankyo Co., Ltd., was established in 2005 through the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. Areas of primary focus for Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or atherosclerosis and bacterial infections. For more information, visit www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd. For more information on Daiichi Sankyo, Inc., please visit

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates
2. OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy
3. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
4. Symmetry Medical Updates Full Year 2009 Financial Guidance
5. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
6. CVS Caremark Announces Updates to Flu Vaccine Program
7. NCCN Updates NHL Guidelines Following FDA Approval of Pralatrexate
8. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
9. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
10. CuraGen Updates CR011-vcMMAE Data at ASCO
11. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... Jonathan Lloyd Jones to the position of ... Mr. Lloyd Jones brings to ... and business development experience.   Most recently, Mr. Lloyd ...
(Date:5/6/2015)... , May 6, 2015 ... maintenance therapy with dolutegravir and rilpivirine   ... of a Phase III clinical trial programme to ... and rilpivirine (Edurant® [1] ) as maintenance therapy ... programme comprises two replicate studies evaluating 48 week ...
(Date:5/5/2015)... , LONDON and NEW YORK ... on ASEAN respiratory devices with a detailed analysis of:   ... diagnostic   - Markets such as Indonesia ... Philippines , Singapore , Thailand ... Australia , New Zealand and ...
Breaking Medicine Technology:Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 2Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 3Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 5
... , BEDFORD, Mass., Nov. 25 Hologic, Inc. (Hologic ... manufacturer and supplier of premium diagnostics, medical imaging systems and ... is using the annual meeting of the Radiological Society of ... through December 3, 2009 to highlight our new SecurView(®) DX ...
... 25 BioTrends Research Group, Inc. released Wave 1 of ... report, the first in a multi-phase syndicated market research ... launch through the first six months of availability. Each ... Dermatologists and qualitative information from a subset of 20. ...
Cached Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2
(Date:5/6/2015)... York (PRWEB) May 06, 2015 Dr. Vito ... facial plastic surgeons , recently completed a medical mission trip ... surgery on those affected by microtia and other deformities ... on April 17 and ended on April 26, Dr. Quatela ... patients. Microtia is a congenital deformity where the outside of ...
(Date:5/6/2015)... The Florida Council on Compulsive Gambling, ... Victory, Miami Area Geriatric Education Center, Mental Health Association ... Commission on Substance Abuse, will hold its annual conference ... the Riverside Hotel. , This important event will address ... as well as clinical training for problem gambling treatment ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 MBLM ... creative and technology, announced today that its founder and ... by Shocase, a marketing professional network aimed at connecting ... , Widely regarded as a specialist in the corporate ... high-profile branding programs over the last three decades, including ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com ... will give away a deluxe human hair lace wig valued ... to enter on a third-party giveaway tool. The important thing ... be the winner. , The hair is a crown, a ... for such a jewel for the past 20 years. Whether ...
(Date:5/6/2015)... May 06, 2015 Most people in the ... nursing or other care after age 65. But less than ... for it or even talking about it, reports the May ... people risk two problems. One is losing control over the ... families," says Dr. David Grabowski, a professor of health care ...
Breaking Medicine News(10 mins):Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2
... patterns of thousands of individuals living in different geographical ... becomes coupled to so-called local sun time despite the ... common "social time" that is determined by time zones. ... dwellers appear to experience a relatively decreased influence of ...
... drug plans between politicians and the common man. The finding ... common Canadian gets// only a partial cover under the public ... a formidable body, that takes the cause of seniors forward, ... drug plans of elected and public officials, with that of ...
... A Leeds University scientist, Simon Carding, has genetically altered ... disease or IBD//. , The bacterium ; Bacterium ... gut, was engineered to produce human growth factors called ... in the gut damaged by the disease, hence reducing ...
... Heather van der Lely, director of the Centre for ... London has developed// a test to identify dyslexia. ... for a range of language disorders, including dyslexia, by ... half a million children suffer from a language problem ...
... an ideal destination for medical tourism, the state's tourism department plans ... Sri Lanka and the Maldives. ,"A policy is ... have asked the CII (Confederation of Indian Industries) to give inputs ... shortly we would become the first state in the country to ...
... who sleep eight hours or more may have shorter life spans ... say the study is flawed//. ,Based on a nationwide survey ... University of California and others found that those who slept eight ... six years than those who got 6 1/2 to 7 1/2 ...
Cached Medicine News:Health News:Chronotype, a Measure to Assess Patterns of Daily Activities 2Health News:‘Sweet Revenge’ on Inflammatory Bowel Disea 2
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Medicine Products: